Implementation of a computerized decision support system to improve the appropriateness of antibiotic therapy using local microbiologic data

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Rodriguez Maresca, Manuel ^a   Sorlozano, Antonio ^b   Grau, Magnolia ^a   Rodriguez Castaño, Rocio ^a   Ruiz Valverde, Andres ^a   Gutierrez Fernandez, Jose ^b,c  

^a HOSPITAL TORRECÁRDENAS   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; CARBAPENEM DERIVATIVE; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN; VANCOMYCIN; ANTIINFECTIVE AGENT; PRESCRIPTION DRUG;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; APACHE; ARTICLE; BLOOD CULTURE; CHILD; DECISION SUPPORT SYSTEM; EPIDEMIOLOGICAL DATA; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE COCCI; HOSPITAL INFECTION; HUMAN; INAPPROPRIATE PRESCRIBING; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION SYSTEM; MORTALITY; PRESCRIPTION; PROSPECTIVE STUDY; QUASI EXPERIMENTAL STUDY; URINE CULTURE; BACTERIUM; CROSS INFECTION; DRUG EFFECTS; ELECTRONICS; HEALTH CARE PLANNING; ISOLATION AND PURIFICATION; MICROBIOLOGY;

ANTI-BACTERIAL AGENTS; BACTERIA; CROSS INFECTION; DECISION SUPPORT SYSTEMS, CLINICAL; DRUG RESISTANCE, BACTERIAL; ELECTRONICS, MEDICAL; FEMALE; HEALTH PLAN IMPLEMENTATION; HEALTH PLANNING GUIDELINES; HUMANS; LENGTH OF STAY; MALE; PRESCRIPTION DRUGS;

EID: 84907481813     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/395434     Document Type: Article

References (32)

1. D. M. Livermore and A. Pearson, "Antibiotic resistance: location, location, location," Clinical Microbiology and Infection, vol. 13, supplement 2, pp. 7-16, 2007.
2. M. S. Niederman, "Appropriate use of antimicrobial agents: challenges and strategies for improvement," Critical Care Medicine, vol. 31, no. 2, pp. 608-616, 2003.
3. G. Höffken and M. S. Niederman, "Nosocomial pneumonia: the importance of a de-escalating strategy for antibiotic treatment of pneumonia in the ICU," Chest, vol. 122, no. 6, pp. 2183-2196, 2002.
4. E. H. Ibrahim, G. Sherman, S. Ward, V. J. Fraser, and M. H. Kollef, "The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting," Chest, vol. 118, no. 1, pp. 146-155, 2000.
5. M. Iregui, S. Ward, G. Sherman, V. J. Fraser, and M. H. Kollef, "Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia," Chest, vol. 122, no. 1, pp. 262-268, 2002.
6. M. H. Kollef, "Diagnosis of ventilator-associated pneumonia," The New England Journal of Medicine, vol. 355, no. 25, pp. 2691-2693, 2006.
7. K. E. Kollef, G. E. Schramm, A. R. Wills, R. M. Reichley, S. T. Micek, and M. H. Kollef, "Predictors of 30-day mortality and hospital costs in patients with ventilator-associated pneumonia attributed to potentially antibiotic-resistant gram-negative bacteria," Chest, vol. 134, no. 2, pp. 281-287, 2008.
8. S. Lee, C.-C. Hua, T.-J. Yu, W. B. Shieh, and L. See, "Risk factors of mortality for nosocomial pneumonia: importance of initial anti-microbial therapy," International Journal of Clinical Practice, vol. 59, no. 1, pp. 39-45, 2005.
9. G. Peralta, M. B. Sánchez, J. C. Garrido et al., "Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia," Journal of Antimicrobial Chemotherapy, vol. 60, no. 4, pp. 855-863, 2007.
10. J. Rello, "Importance of appropriate initial antibiotic therapy and de-escalation in the treatment of nosocomial pneumonia," European Respiratory Review, vol. 16, no. 103, pp. 33-39, 2007.
11. G. W. Soo Hoo, Y. E. Wen, T. V. Nguyen, and M. B. Goetz, "Impact of clinical guidelines in the management of severe hospital-acquired pneumonia," Chest, vol. 128, no. 4, pp. 2778-2787, 2005.
12. J. Vallés, J. Rello, A. Ochagavía, J. Garnacho, and M. A. Alcalá, "Community-acquired bloodstream infection in critically III adult patients: impact of shock and inappropriate antibiotic therapy on survival," Chest, vol. 123, no. 5, pp. 1615-1624, 2003.
13. T. H. Dellit, J. D. Chan, S. J. Skerrett, and A. B. Nathens, "Development of a guideline for the management of ventilator-associated pneumonia based on local microbiologic findings and impact of the guideline on antimicrobial use practices," Infection Control and Hospital Epidemiology, vol. 29, no. 6, pp. 525-533, 2008.
14. A. Zapantis, M. K. Lacy, R. T. Horvat et al., "Nationwide antibiogram analysis using NCCLS M39-A guidelines," Journal of Clinical Microbiology, vol. 43, no. 6, pp. 2629-2634, 2005.
15. American Thoracic Society and Infectious Diseases Society of America, "Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia," American Journal of Respiratory and Critical Care Medicine, vol. 171, no. 4, pp. 388-416, 2005.
16. L. A. Mermel, M. Allon, E. Bouza et al., "Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America," Clinical Infectious Diseases, vol. 49, no. 1, pp. 1-45, 2009.
17. C. Rotstein, G. Evans, A. Born et al., "Clinical practice guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia in adults," Canadian Journal of Infectious Diseases and Medical Microbiology, vol. 19, no. 1, pp. 19-53, 2008.
18. J. R. Beardsley, J. C. Williamson, J. W. Johnson, C. A. Ohl, T. B. Karchmer, and D. L. Bowton, "Using local microbiologic data to develop institution-specific guidelines for the treatment of hospital-acquired pneumonia," Chest, vol. 130, no. 3, pp. 787-793, 2006.
19. F. Álvarez-Lerma, B. Alvarez, P. Luque et al., "Empiric broad-spectrum antibiotic therapy of nosocomial pneumonia in the intensive care unit: a prospective observational study," Critical Care, vol. 10, no. 3, article R78, 2006.
20. G. Wilson, S. Badarudeen, and A. Godwin, "Real-time validation and presentation of the cumulative antibiogram and implications of presenting a standard format using a novel in-house software: ABSOFT," American Journal of Infection Control, vol. 38, no. 9, pp. e25-e30, 2010.
21. T. H. Dellit, R. C. Owens, J. E. McGowan Jr. et al., "Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship," Clinical Infectious Diseases, vol. 44, no. 2, pp. 159-177, 2007.
22. J. Rodríguez-Baño, J. R. Paño-Pardo, L. Alvarez-Rocha et al., "Programs for optimizing the use of antibiotics (PROA) in Spanish hospitals: GEIH-SEIMC, SEFH and SEMPSPH consensus document," Enfermedades Infecciosas y Microbiologiã Cliñica, vol. 30, no. 1, pp. 22.e1-22.e23, 2012.
23. S. Deuster, I. Roten, and S. Muehlebach, "Implementation of treatment guidelines to support judicious use of antibiotic therapy," Journal of Clinical Pharmacy and Therapeutics, vol. 35, no. 1, pp. 71-78, 2010.
24. E. H. Eiland III, K. A. Wargo, W. Hamm, and A. A. M. Hassoun, "Analysis of adherence to national nosocomial pneumonia treatment guidelines," Therapeutics and Clinical Risk Management, vol. 3, no. 6, pp. 983-988, 2007.
25. E. H. Ibrahim, S. Ward, G. Sherman, R. Schaiff, V. J. Fraser, and M. H. Kollef, "Experience with a clinical guideline for the treatment of ventilator-associated pneumonia," Critical Care Medicine, vol. 29, no. 6, pp. 1109-1115, 2001.
26. W. A. Knaus, E. A. Draper, D. P.Wagner, and J. E. Zimmerman, "APACHE II: a severity of disease classification system," Critical Care Medicine, vol. 13, no. 10, pp. 818-829, 1985.
27. J.-L. Vincent, R. Moreno, J. Takala et al., "The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine," Intensive Care Medicine, vol. 22, no. 7, pp. 707-710, 1996.
28. R. S. Evans, S. L. Pestotnik, D. C. Classen et al., "A computer-assisted management program for antibiotics and other antiinfective agents," The New England Journal of Medicine, vol. 338, no. 4, pp. 232-238, 1998.
29. S. L. Pestotnik, "Expert clinical decision support systems to enhance antimicrobial stewardship programs: insights from the society of infectious diseases pharmacists," Pharmacotherapy, vol. 25, no. 8, pp. 1116-1125, 2005.
30. K. Kawamoto, C. A. Houlihan, E. A. Balas, and D. F. Lobach, "Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success," British Medical Journal, vol. 330, no. 7494, pp. 765-768, 2005.
31. K. A. Thursky, K. L. Buising, N. Bak et al., "Reduction of broad-spectrum antibiotic use with computerized decision support in an intensive care unit," International Journal for Quality in Health Care, vol. 18, no. 3, pp. 224-231, 2006.
32. M. D. Cabana, C. S. Rand, N. R. Powe et al., "Why don't physicians follow clinical practice guidelines? A framework for improvement," Journal of the American Medical Association, vol. 282, no. 15, pp. 1458-1465, 1999.